Drug Trial Radar · NCT07479485
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
Last checked: Nov 19, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Apr 8, 2026
Primary completion
Apr 2028
Study completion Apr 2029
Sponsor
- Lead sponsor
- Lepu Biopharma Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, multicenter, Phase I/II clinical study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of MRG006A in combination with immune checkpoint inhibitors and targeted therapy in patients with advanced hepatocellular carcinoma (HCC).
Conditions
- Hepatocellular Carcinoma
Interventions
MRG006ADrug
Administrated intravenously
PucotenlimabDrug
Administrated intravenously
BevacizumabDrug
Administrated intravenously
PD1/VEGF antibodyDrug
Administrated intravenously
TKIDrug
Administrated intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: Up to 2 years
- Recommended Phase 2 DoseTime frame: 1 year
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Beijing You An Hospital, Capital Medical University
Beijing, Beijing Municipality, China · Not yet recruiting
The Ethics Committee of Cancer Hospital Chinese Academy of Medical Sciences.
Beijing, Beijing Municipality, China · Recruiting
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Mengchao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, China · Not yet recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hospital With Nanjing Medical University
Nanjing, Jiangsu, China · Not yet recruiting
Tianjin Cancer Hospital Airport Hospital
Tianjin, Tianjin Municipality, China · Not yet recruiting
Lishui Central Hospital
Lishui, Zhejiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.